Unexpected correlation in the sensitivity of 19 herpes simplex virus strains to types I and II interferons

Journal of Interferon and Cytokine Research

Volumn 17, Issue 9, 1997, Pages 537-541

  Arao, Y ^a   Ando, Y ^a,b   Narita, M ^a,b   Kurata, T ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; LYMPHOBLAST INTERFERON; MONOCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CELL; STRAIN DIFFERENCE; VIRUS INHIBITION; VIRUS REPLICATION;

ALPHAVIRUS; HERPES; SIMPLEXVIRUS;

EID: 0030661745     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.537     Document Type: Article

References (29)

1. CHATTERJEE, S., LAKEMAN, A.D., WHITLEY, R.J., and HUNTER, E. (1984). Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Res. 1, 81-87.
2. OBERMAN, F., and PANET, A. (1988). Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J. Gen. Virol. 69, 1167-1177.
3. DE STASIO, P.R., and TAYLOR, M.W. (1990). Specific effect of interferon on the herpes simplex virus type 1 transactivation event. J. Virol. 64, 2588-2593.
4. KAUFMAN, H.E., ELLISON, E.D., and CENTIFANTO, Y.M. (1972). Difference in interferon response and protection from ocular virus infection in rabbits and monkeys. Am. J. Ophthalmol. 74, 89-92.
5. JONES, B.R., COSTER, D.J., FALCON, M.G., and CANTELL, K. (1976). Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet 2, 128.
6. SU, Y.-H., OAKES, J.E., and LAUSCH, R.N. (1990). Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64, 2187-2192.
7. LAUSCH, R.N., SU, Y.-H., RITCHIE, M., and OAKES, J.E. (1991). Evidence endogenous interferon production contributed to the lack of ocular virulence of an HSV intertypic recombinant. Curr. Eye Res. 10, 39-45.
8. SANITATO, J.J., VARNELL, E.D., KAUFMAN, H.E., and RAJU, V.K. (1984). Diffuse in natural and recombinant interferon for herpes keratitis in two animal models. Invest. Ophthalmol. Vis. Sci. 25, 874-876.
9. PINTO, A.J., MORAHAN, P.S., BRINTON, M., STEWART, D., and GAVIN, E. (1990). Comparative therapeutic efficacy of recombinant interferon-α, -β, and -γ against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J. Interferon Res. 10, 293-298.
10. HENDRICKS, R.L., WEBER, P.C., TAYLOR, J.L., KOUMBIS, A., TUMPEY, T.M., and GLORIOSO, J.C. (1991). Endogeneously produced interferon α protects mice from herpes simplex virus type 1 corneal disease. J. Gen. Virol. 72, 1601-1610.
11. MITTNACHT, S., STRAUB, P., KIRCHNER, H., and JACOBSEN, H. (1988). Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164, 201-210.
12. KLOTZBÜCHER, A., MITTNACHT, S., KIRCHNER, H., and JACOBSEN, H. (1990). Different effects of IFNγ and IFNα/β on "immediate early" gene expression of HSV-1. Virology 179, 487-491.
13. BALISH, M.J., ABRAMS, M.E., PUMFERY, A.M., and BRANDT, C.R. (1992). Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-α and -γ. J. Infect. Dis. 166, 1401-1403.
14. ZERIAL, A., HOVANESSIAN, A.G., STEFANOS, S., HUYGEN, K., WERNER, G.H., and FALCOFF, E. (1982). Synergistic activities of type I (α,β) and type II (γ) murine interferons. Antiviral Res. 2, 227-239.
15. KIGASAWA, K., SOUSHI, S., TANAKA, Y., and OBAZAWA, H. (1994). Morphologic and chromosomal study of a human retinal pigment epithelial cell line. Jpn. J. Ophthalmol. 38, 10-15.
16. KIGASAWA, K., OBAZAWA, H., SOUSHI, S., and TANAKA, Y. (1995). Histochemical demonstration of acid phosphatase in a human retinal pigment epithelial cell line. Tokai J. Exp. Clin. Med. 20, 31-35.
17. DREESMAN, G.R., and BENYESH-MELNICK, M. (1967). Spectrum of human cytomegalovirus complement-fixing antigens. J. Immunol. 99, 1106-1114.
18. EJERCITO, P.M., KIEFF, E.D., and ROIZMAN, B. (1968). Characterization of herpes simplex virus strains differing in their effect on social behavior of infected cells. J. Gen. Virol. 2, 357-364.
19. NII, S., YAMADA, M., and UNO, F. (1983). Giant cell-forming variants of the Miyama strain of type 1 herpes simplex virus which differ in fusion activity. Biken J. 26, 127-131.
20. NII, S., and KAMAHORA, J. (1961). Studies on the growth of a newly isolated herpes simplex virus in vitro. Biken J. 4, 75-96.
21. HOGGAN, M.D., and ROIZMAN, B. (1959). The isolation and properties of a variant of herpes simplex producing mullinucleated giant cells in monolayer cultures in the presence of antibody. Am. J. Trop. Hyg. 70, 208-219.
22. YOSHINO, K., and TANIGUCHI, S. (1969). Isolation of a clone of herpes simplex virus highly attenuated for newborn mice and hamsters. Jpn. J. Exp. Med. 39, 223-232.
23. HATANO, A., ARAO, Y., and NII, S. (1990). Pathogenicity of herpes simplex virus type 1 in mice after the intranasal route of inoculation. In: Proceeding of XIV Congress of Otorhinolaryngology Head and Neck Surgery. T. Sacristán, J.J. Alvarez-Vicent, J. Bartual, and F. Antolí-Candela (eds.) Amsterdam, Berkeley, Milano: Kugler and Ghedini Publications, pp. 2945-2949.
24. BROWN, S.M., RITCHIE, D.A., and SUBAK-SHARPE, J.H. (1973). Genetic studies with herpes simplex virus type 1: isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J. Gen. Virol. 18, 329-341.
25. TIMBURY, M.C. (1971). Temperature-sensitive mutants of herpes simplex virus type 2. J. Gen. Virol. 13, 373-376.
26. CHIANG, W., WENTWORTH, B.B., and ALEXANDER, E.R. (1970). The use of an immunofluorescence technique for the determination of antibodies to cytomegalovirus strains in human sera. J. Immunol. 104, 992-999.
27. CHEN, S.-H., OAKES, J.E., and LAUSCH, R.N. (1994). Synergistic antiherpes effect of TNF-α and IFN-γ in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 25, 201-213.
28. ITO, M, and O'MALLEY, J.A. (1987). Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res. 6, 309-318.
29. BARON, S., and DIANZANI, F. (1994). The interferons: a biological system with therapeutic potential in viral infections. Antiviral Res. 24, 97-110.